Table 5.

Lessons Learned

• Design pharmacogenomics implementation program for the health system patient population

• Identify a physician champion and engage key stakeholders

• Target the right patient population for preemptive testing

• Preemptive testing reduced issues around TAT, but introduced challenges with patient identification and reimbursement

• Engage and educate clinicians early and repeatedly throughout the implementation process

• Partner with hospital informatics to create clinical decision support tools and solve ongoing EHR challenges

• A designated person or team to respond to results improves efficiency of therapy changes

• Integrate clinical pharmacists to ensure adherence to the implementation algorithm and appropriate follow-up

• Provide ongoing education programs for all health care providers

• Learn from published experiences of early implementers, domain expert groups (CPIC)